Diff: 3p- Syndrome
Comparing revision #1 (2023-06-10 00:00:25) with revision #2 (2026-06-22 10:11:05).
| Old | New |
|---|---|
'''3p deletion syndrome''', also written as '''3p- syndrome''', is a rare chromosomal deletion syndrome caused by the loss of genetic material from the short arm of [[Chromosome_3|chromosome 3]]. |
|
3p- syndrome, also known as 3p deletion syndrome or 3p deletion, is a rare genetic disorder caused by the deletion of a portion of the short arm (p) of chromosome 3. The specific region deleted can vary among individuals, leading to some variability in the clinical features observed. 3p- syndrome is characterized by developmental delays, intellectual disabilities, distinctive facial features, and other physical and medical abnormalities. |
|
The deleted segment is usually at the end of the short arm, known as the p arm. The size and position of the deletion can vary, so symptoms are not identical in every affected person. |
|
== Presentation and Clinical Features == |
|
Individuals with 3p- syndrome often exhibit delayed development and intellectual disabilities. The extent of the developmental delay can vary, with some individuals experiencing mild delays while others have more significant impairments. Speech and language delays are common, and affected individuals may require assistance in developing effective communication skills. |
|
== Features == |
|
3p deletion syndrome is usually associated with developmental delay, intellectual disability and physical differences. Speech and language delay are common. |
|
Distinctive facial features are a hallmark of 3p- syndrome. These may include a prominent forehead, a broad nasal bridge, a long philtrum (groove between the nose and upper lip), a thin upper lip, and a small chin. Other physical characteristics can include low muscle tone (hypotonia), joint hypermobility, and poor coordination. |
|
Reported features can include: |
|
In addition to developmental and physical features, individuals with 3p- syndrome may have medical complications. These can include heart defects, kidney abnormalities, eye problems, hearing loss, seizures, and gastrointestinal issues. |
|
* delayed motor development |
|
* learning disability or intellectual disability |
|
* low muscle tone |
|
* growth delay |
|
* distinctive facial features |
|
* small head size in some cases |
|
* feeding difficulty |
|
* seizures in some affected people |
|
* heart, kidney, eye or hearing problems in some cases |
|
The pattern depends on which genes are missing and whether other chromosomal changes are present. |
|
== Genetic Cause == |
== Genetic Cause == |
3p- syndrome is typically caused by a deletion of genetic material on the short arm of chromosome 3. The size and location of the deletion can vary, resulting in some variation in the clinical features observed. The deletion can occur as a de novo (spontaneous) event during early embryonic development or be inherited from an affected parent who also carries the deletion. |
|
The condition is caused by deletion of part of chromosome 3p. Many cases occur as a new event during the formation of reproductive cells or early embryonic development. |
|
The exact genes responsible for the specific features of 3p- syndrome are not fully understood. However, it is believed that the loss of certain genes within the deleted region contributes to the characteristic developmental, intellectual, and physical features of the syndrome. |
|
Some cases are inherited. A parent may have a balanced chromosomal rearrangement or a smaller deletion with mild or unnoticed features. Genetic testing of parents can therefore be important after a child is diagnosed. |
|
== Diagnosis and Management == |
|
Diagnosis of 3p- syndrome is typically based on clinical evaluation, physical examination, and genetic testing. Chromosomal microarray analysis (CMA) is the most commonly used genetic test to identify the deletion on chromosome 3. Prenatal diagnosis is possible through invasive testing procedures such as chorionic villus sampling (CVS) or amniocentesis. |
|
== Diagnosis == |
|
Diagnosis is made through genetic testing. Chromosomal microarray is commonly used because it can detect small deletions that may not be visible on a standard karyotype. |
|
Management of 3p- syndrome focuses on addressing the specific needs and challenges of each affected individual. Early intervention services, including physical therapy, speech therapy, and occupational therapy, can help support development and improve functional skills. Educational programs tailored to the individual's needs are also important to maximize learning potential. |
|
Other tests may be used depending on the individual, including chromosome analysis, targeted testing of parents, heart scans, kidney scans, hearing tests, eye examination and developmental assessment. |
|
Regular monitoring for associated medical conditions is essential, as prompt identification and treatment can improve outcomes. Multidisciplinary care involving medical specialists, therapists, and educators can provide comprehensive support for individuals with 3p- syndrome and their families. |
|
== Management == |
|
Management depends on the person's needs rather than the name of the syndrome alone. Early developmental support is usually important. |
|
== Research and Future Perspectives == |
|
Further research is needed to better understand the specific genes and molecular mechanisms involved in 3p- syndrome. Studying individuals with different-sized deletions and correlating their clinical features with the affected genes can contribute to a deeper understanding of the syndrome's variability and underlying biological processes. |
|
Care may include: |
|
Advancements in genetic technologies, such as whole-genome sequencing, may help identify additional genes within the deleted region that contribute to the clinical features of 3p- syndrome. Animal models and cellular studies can also provide insights into the role of specific genes and pathways in normal development and disease progression. |
|
* speech and language therapy |
|
* physiotherapy |
|
* occupational therapy |
|
* educational support |
|
* monitoring for seizures |
|
* hearing and eye care |
|
* assessment for heart or kidney differences |
|
* genetic counselling for the family |
|
Collaborative efforts among researchers, healthcare professionals, and families affected by 3p- syndrome can facilitate the sharing of knowledge and experiences, leading to improved diagnosis, management, and support for individuals living with this rare genetic disorder. |
|
There is no single treatment that reverses the chromosomal deletion. Support focuses on development, communication, health monitoring and practical independence. |
|
== Prognosis == |
|
The outlook varies with the size of the deletion and the medical complications present. Some affected people need significant lifelong support, while others have milder difficulties. |
|
Clear genetic results can help families and clinicians understand recurrence risk and plan health checks, but they do not always predict exact future development. |
|
== Terminology == |
|
The name '''3p-''' means that material is missing from chromosome 3p. The minus sign is a cytogenetic shorthand for deletion. |
|
The condition should not be confused with [[3q29_microdeletion_syndrome|3q29 microdeletion syndrome]], which affects the long arm of chromosome 3 and has a different genetic location. |
|
== See Also == |
|
* [[Chromosome_3]] |
|
* [[Genetic_Disorder]] |
|
* [[Chromosomal_Deletion]] |
|
== References == |
== References == |
* [https://medlineplus.gov/genetics/condition/3p-deletion-syndrome/ MedlinePlus Genetics: 3p deletion syndrome] |
|
* [https://www.orpha.net/en/disease/detail/1620 Orphanet: Distal deletion 3p syndrome] |
|
* [https://rarechromo.org/media/information/Chromosome%20%203/3p25deletions%202022%20FTNW.pdf Unique: 3p25 deletions] |
|
* [https://pmc.ncbi.nlm.nih.gov/articles/PMC7902511/ Case report and literature review of 3p deletion syndrome] |
|
# Ballif BC, Theisen A, Coppinger J, et al. Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication. Mol Cytogenet. 2008;1:8. doi:10.1186/1755-8166-1-8 |
|
# Battaglia A. The inv dup (15) or idic (15) syndrome (Tetrasomy 15q). Orphanet J Rare Dis. 2008;3:30. doi:10.1186/1750-1172-3-30 |
|
# Mainardi PC. Cri du Chat Syndrome. Orphanet J Rare Dis. 2006;1:33. doi:10.1186/1750-1172-1-33 |
|
# Meyer E, Carss KJ, Rankin J, et al. Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia. Nat Genet. 2017;49(2):223-237. doi:10.1038/ng.3734 |
|
[[Category:Genetics]] |
|
[[Category:Medicine]] |
|
[[Category:Chromosomal Disorders]] |